Ideas
Buy Korean large caps on dips
Korean liquidity is ample and foreign investors have already reduced exposure; the KOSPI around 4,900 is historically undervalued versus its 10-year forward P/E average, so split buying into large caps is attractive. If growth-stock leadership cracks, capital can rotate to banks and financials.
Buy Korean banks on value rotation
If growth and mega-cap technology leadership cracks, value and dividend financials should attract rotation. Korean banks have low PBRs, improving shareholder returns, and KB Financial's 50%+ payout shows the momentum; banks are more comfortable short term, while securities can follow if trading volume increases.
Korean solar and Hanwha can rally
China's reduction of solar subsidies and SpaceX-related space-solar sentiment are positive for solar prices and Korean solar makers. Hanwha Solutions is the main beneficiary, with additional potential from perovskite and space-use solar materials, and the long-dormant sector can attract aggressive money.
Foreign underweight semis can rebound
Foreign ownership in Samsung Electronics and SK hynix has fallen sharply, while foreign selling appears largely exhausted and earnings remain strong. If foreign buying returns, the Korean semiconductor leaders can rebound, supported by the market's low valuation.
Analyst upgrades lift Hanwha Solutions
Hanwha Solutions received simultaneous analyst rating upgrades and target-price hikes to 45,000-50,000 won after a long period of no updates. The stock trades around 0.8-0.9x PBR, and the market rewards fresh report changes when other sectors are fully priced; loss-to-profit turnaround supports the move.
Securities benefit from trading volume
If market trading volume rises, Korean brokerage stocks should be the next beneficiary; he finds securities more attractive than banks, even though banks are more comfortable short term.
Korean telecom equipment may re-rate
US efforts to exclude Chinese telecom gear and new frequency auctions could open opportunities for Korean telecom equipment makers. Open RAN compatibility and space/satellite links add optionality, and the dormant sector is showing renewed volatility.
SK Telecom needs dividend commitment
SK Telecom sold off on poor earnings after an Anthropic-related run-up, but medium- to long-term valuation may be re-rated if the company shows a firm dividend commitment; watch for that catalyst before expecting a rebound.
Buy Korean semis on dips
Samsung Electronics and SK hynix earnings estimates are rising with memory prices, but the stocks ran too fast in one month; this is a speed correction, not a broken cycle. Semiconductors remain the most attractive Korean area on pullbacks and likely the strongest into the second half, so new money should buy only on sharp dips.
Buy strong Korean biotech on dips
After a sharp KOSDAQ biotech selloff, selling now is late; if the market does not break, survivors like Celltrion, Hanmi Pharm, and Sam Chun Dang Pharm are better new-entry candidates, while heavily fallen names may keep lagging. Use only 10-20% of the portfolio.
Korea can re-rate over years
Korea is structurally improving through better EPS and policy/shareholder-return reforms that can lift the multiple; over several years the market can re-rate, although the path will be bumpy and requires cash discipline.
Korea can re-rate over years
Buy large caps that generate cash and return it through dividends and buybacks. In a higher-discount-rate market these are more resilient and are what foreign investors will select as Korea moves toward developed-market style investing.
Stay long Samsung and SK hynix
Samsung Electronics and SK hynix are cheap on strong memory earnings, but the key risk is growth-rate deceleration. He remains long-term bullish and sees further upside, though the slope may flatten and cause volatility.
Avoid Korean theme and small caps
In a regime of higher risk premiums and volatility, theme-driven small/mid caps and leveraged bets are dangerous; many investors who chase daily themes can give back gains. Focus should stay on quality large caps.
Wonik IPS benefits from pulled capex
An analyst upgraded both earnings and multiple for Wonik IPS, and Samsung/SK hynix pulling forward capex benefits its equipment. The target was raised to 130,000-140,000 won and could reach 180,000 won if the Pyeongtaek schedule is confirmed; hold through non-fundamental drops.
Eugene Tech is cheaper equipment play
Eugene Technology's analyst upgrade was mostly a multiple increase rather than an earnings raise, and it trades cheaper than Wonik IPS. It sells to Samsung, SK hynix, and Micron, making it a relative-value equipment play; buy on non-fundamental dips with a 130,000 won target.
TES offers steady equipment upside
The analyst raised TES's EPS estimate by 23% and target to 90,000 won. At around 67,000 won it offers the largest upside among the equipment names, supported by steady 20% growth, making it suitable for investors who prefer steadier growth.
Buy Park Systems on seasonal weakness
Park Systems is a high-quality metrology equipment maker with monopoly-like technology; it is normally expensive but has become cheap. Buy during weak first-quarter seasonality; the target is 370,000 won versus around 240,000 won, and 30x or below is attractive.
Nextin too volatile on China risk
Nextin has technology but high China exposure and volatility; the stock already ran before the analyst report, and he would not take the risk unless the investor can tolerate China-related swings.
Watch US semis for Korea signal
For the KOSPI to break above 5,200-5,300, US semiconductor names like SanDisk, Micron, Broadcom, and Nvidia need to rise together; if they cannot, new buying in Korea should stay cautious. This is a monitoring signal for Korean semiconductors.
Netmarble depends on gaming sentiment
Netmarble has strong new-game momentum and shareholder returns including treasury share cancellation; analysts disagree on target P/E, but if gaming-sector interest returns the P/E can be adjusted upward. It is a watch, not a clean value call.
KB Financial gains on shareholder returns
KB Financial's fourth-quarter earnings beat, NIM expansion, one-off charge reversal, and 52% shareholder-return target make it a leading Korean bank. The target price was raised to 165,000 won and it can re-rate further on capital return.
Celltrion margins and CMO improve
Celltrion's biosimilar prescriptions are growing despite doctor reluctance, CMO volumes from Lilly start in February, and operating margin has reached the mid-30% range. Shinhan raised its target to 290,000 won and the structural improvement supports a positive view.
This 3PRO TV (삼프로TV) video, published February 06, 2026,
features Lee Jae-kyu, Kim Jang-yeol, Yoon Ji-ho, Choi Young-joo
discussing ^KS11, 105560.KS, 086790.KS, 316140.KS, 055550.KS, 138930.KS, 139130.KS, 009830.KS, Korean solar sector, 005930.KS, 000660.KS, Korean securities/brokerage sector, 218410.KQ, 050890.KQ, Korean telecom equipment sector, 017670.KS, 068270.KS, 128940.KS, 000250.KQ, Korean Biotech/Pharma Sector, KOSPI large caps, ^KQ11, Korean small/mid-cap stocks, Korean theme stocks, 240810.KQ, 084370.KQ, 095610.KQ, 140860.KQ, 348210.KQ, SNDK, MU, AVGO, NVDA, 251270.KS.
23 trade ideas extracted by AI with direction and confidence scoring.
Speakers:
Lee Jae-kyu,
Kim Jang-yeol,
Yoon Ji-ho,
Choi Young-joo
· Tickers:
^KS11,
105560.KS,
086790.KS,
316140.KS,
055550.KS,
138930.KS,
139130.KS,
009830.KS,
Korean solar sector,
005930.KS,
000660.KS,
Korean securities/brokerage sector,
218410.KQ,
050890.KQ,
Korean telecom equipment sector,
017670.KS,
068270.KS,
128940.KS,
000250.KQ,
Korean Biotech/Pharma Sector,
KOSPI large caps,
^KQ11,
Korean small/mid-cap stocks,
Korean theme stocks,
240810.KQ,
084370.KQ,
095610.KQ,
140860.KQ,
348210.KQ,
SNDK,
MU,
AVGO,
NVDA,
251270.KS
